分化型甲状腺癌患者放射性碘全身扫描加做SPECT/CT的临床意义:系统评价与Meta分析
该系统评价与Meta分析纳入30项研究(前瞻性9项、回顾性21项),比较分化型甲状腺癌患者放射性碘全身扫描加做SPECT/CT与单纯全身扫描的结论性判读率和治疗方案改变频率。加做SPECT/CT提高了颈部、颈外及全部区域的结论性判读率,并导致诊断性扫描后30%、治疗后扫描后9%的治疗方案改变,但证据质量和推荐强度均为低。
要点
- 加做SPECT/CT提高颈部病灶结论性判读率:基于病灶分析提高14%,基于扫描分析提高27%。
- 加做SPECT/CT提高颈外病灶结论性判读率:基于病灶分析提高20%,基于扫描分析提高9%。
- 加做SPECT/CT导致诊断性扫描后30%、治疗后扫描后9%的治疗方案改变。
核心结论
- 有力证据表明,全身扫描加做SPECT/CT可改善分化型甲状腺癌患者的病灶定位、诊断性能和治疗方案。
研究设计与样本
- 系统评价与Meta分析,遵循PRISMA指南,PROSPERO注册号CRD42022341732。
- 检索MEDLINE、EMBASE和Cochrane数据库,纳入2023年8月16日前发表的文献。
- 共纳入30项研究,其中前瞻性9项、回顾性21项。
- 采用RoBANS 2.0工具评估偏倚风险,采用GRADE系统评价证据质量和推荐强度。
主要发现
- 加做SPECT/CT提高颈部病灶结论性判读率:基于病灶分析提高14%,基于扫描分析提高27%。
- 加做SPECT/CT提高颈外病灶结论性判读率:基于病灶分析提高20%,基于扫描分析提高9%。
- 加做SPECT/CT提高全部区域结论性判读率:基于病灶分析提高18%,基于扫描分析提高34%。
- 加做SPECT/CT导致诊断性扫描后30%的治疗方案改变,治疗后扫描后9%的治疗方案改变。
关键数值与推荐
- 证据质量和推荐强度均为低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 证据质量和推荐强度均为低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to determine the usefulness of adding SPECT/CT to radioiodine whole-body scans (WBSs) for the treatment of differentiated thyroid cancer (DTC). PATIENTS AND METHODS: A systematic review and meta-analysis were performed following the PRISMA guidelines (PROSPERO registration: CRD42022341732) to compare the feasibility of conclusive readings and the frequency of changes in treatment plans in patients with DTC undergoing WBS + SPECT/CT versus WBS. MEDLINE, EMBASE, and Cochrane databases were searched to identify relevant articles concerning thyroid cancer, radioactive iodine, and SPECT/CT or SPECT, published before August 16, 2023. Studies not comparing WBS + SPECT/CT with WBS, those lacking target outcomes, and those not involving human subjects were excluded. The risk of bias was assessed using the RoBANS 2.0 (Risk of Bias Assessment Tool for Nonrandomized Studies) tool. The GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) system was used to evaluate the quality of evidence and strength of recommendations. RESULTS: A total of 30 studies (prospective n = 9, retrospective n = 21) were included in the meta-analyses. Adding SPECT/CT to WBS was shown to increase conclusive readings for cervical lesions, extracervical lesions, and all regions. Lesion-based analyses showed improvements of 14%, 20%, and 18%, respectively, whereas scan-based analyses showed improvements of 27%, 9%, and 34%. The addition of SPECT/CT to WBS led to changes in 30% of treatment plans after diagnostic scans and 9% of treatment plans after posttherapeutic scans. The quality of evidence and strength of recommendations were low. CONCLUSIONS: Compelling evidence demonstrates that the addition of SPECT/CT to WBS improves lesion localization, diagnostic performance, and therapy plan for patients with DTC.
引用
- Chong A, Seo Y, Bang JI, et al. Clinical Implications of Adding SPECT/CT to Radioiodine Whole-Body Scan in Patients With Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis. Clin Nucl Med. 2023. PMID: 38048517. doi:10.1097/RLU.0000000000004953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。